We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Excess Oxygen Worsens Lung Inflammation

By HospiMedica staff writers
Posted on 27 May 2005
A new study has shown that oxygen therapy intended to help mice with acute lung inflammation to breathe had the opposite affect, worsening their illness.

The excess oxygen appeared to thwart a natural process that limits lung tissue damage. More...
Previous research showed that inflammation leads to a drop in oxygen levels in the inflamed tissues, which triggers the release of adenosine from surrounding cells. When adenosine binds to cell receptors in the inflamed region, it serves as a tissue-protecting stop signal, slowing the flood of damaging inflammatory molecules. These findings suggested that oxygen given to patients with acute lung inflammation might short-circuit this protective pathway by preventing oxygen levels from dropping enough to trigger the inflammation stop signal.

Senior author Michail Sitkovsky, Ph.D., and colleagues at the U.S. National Institute of Allergy and Infectious Diseases (NIAID, Bethesda, MD, USA) explored this possibility by inducing lung inflammation in three groups of mice. The first group received no supplemental oxygen. Although these mice sustained moderate lung damage, only two died. Another group of 15 mice with acute lung inflammation were treated with either 100% or 60% oxygen for 48 hours. These mice suffered very extensive lung damage, and 11 of the 15 died. A third group of 15 mice with acute lung inflammation were treated with 100% oxygen and an adenosine-like drug to compensate for the oxygen-induced loss of natural adenosine. Only two mice in this group died.

Highly pure oxygen therapy without the addition of an adenosine substitute worsens pre-existing lung inflammation, concluded the researchers. "We suggest that these adenosine substitutes be evaluated for their possible usefulness in settings of acute lung inflammation due to infection or other causes, such as asthma or surgical trauma,” said Dr. Sitkovsky, who is continuing his research at Northeastern University (Boston, MA, USA). His paper was published in the May 2, 2005, issue of PLoS Biology.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.